Tag: oncology ablation market uk

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Oncology Ablation Market Expected To Become By 2029 Compared With Its 2025 Level?

The oncology ablation market has experienced significant expansion in recent years. It is projected to increase from $1.3 billion in 2024 to $1.45 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.1%. The historical growth can be attributed to several factors, including the rising incidence of cancer, an increasing preference for minimally invasive ablation techniques, higher healthcare spending, the approval of new ablation devices and technologies, improvements in cancer screening programs, and the expansion of the geriatric population.

The oncology ablation market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $2.33 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected growth during the forecast timeframe stems from several factors, including continuous progress in ablation techniques, greater utilization of ablation methods in developing nations, the expansion of personalized and precision medicine, increased government backing and financial provisions for cancer research and treatment breakthroughs, a growing preference for outpatient medical interventions, and heightened public and professional understanding. Key developments anticipated in the forecast period encompass the incorporation of artificial intelligence (AI), enhancements in imaging technologies, the emergence of robotic-assisted ablation, the launch of sophisticated ablation devices offering superior efficacy, safety, and ease of use, and the application of telemedicine for pre- and post-ablation care, facilitating remote oversight and subsequent consultations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Are The Top Growth Drivers Impacting The Oncology Ablation Market Outlook?

The future expansion of the oncology ablation market is anticipated to be driven by the rising frequency of cancer diagnoses. Cancer diagnosis involves identifying and confirming cancer’s presence through medical testing, imaging, and pathological examination of tissue samples. This increase in diagnoses stems from factors like aging demographics, enhanced screening initiatives, greater awareness promoting early detection, and environmental influences. Oncology ablation serves as a treatment for tumors identified via cancer diagnoses, providing minimally invasive approaches to eradicate tumors and enhance patient results. For example, the National Cancer Institute, the US-based federal government’s main agency for cancer research and training, reported in May 2024 that approximately 2,001,140 new cancer cases are projected in the United States in 2024, with prostate, lung, and colorectal cancers accounting for about 48% of all diagnoses in men. Furthermore, by 2040, the yearly incidence of new cancer cases is predicted to rise significantly to 29.9 million. Additionally, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, stated that approximately 1.9 million new cancer cases were diagnosed in the USA in 2022. Consequently, the increasing volume of cancer diagnoses is set to boost the oncology ablation market.

What Are The Emerging Segments Gaining Attention In The Oncology Ablation Market?

The oncology ablationmarket covered in this report is segmented –

1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation; Laparoscopic Ablation; Percutaneous Ablation

3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation; Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation; Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation; Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE; Transperineal IRE; Percutaneous IRE

What Key Innovation Trends Are Fueling Advancements In The Oncology Ablation Market?

Companies actively involved in the oncology ablation market are focused on developing groundbreaking products, encompassing advanced ablation systems that offer enhanced precision, integrated imaging technologies for real-time guidance, and strengthened safety features. These highly precise ablation systems are medical devices that utilize sophisticated technology to accurately target and eliminate abnormal tissue, such as tumors, while minimizing damage to surrounding healthy tissue. For instance, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, obtained US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, designed for treating painful bone metastases and benign tumors like osteoid osteoma. This enhanced system incorporates significant improvements, including the capability to use four internally cooled probes simultaneously, allowing for the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Which Leading Players Are Enhancing Their Oncology Ablation Market Presence Worldwide?

Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Region Is Projected To Lead The Oncology Ablation Market During The Forecast Period?

North America was the largest region in the oncology ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oncology Ablation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2025, By The Business Research Company

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Immuno Oncology Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Oncology Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Oncology Ablation Market Expected to Grow Between 2025 And 2029?

The size of the oncology ablation market has seen a swift increase in recent times. The market is predicted to surge from $1.3 billion in 2024 to $1.46 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.9%. This significant growth during the historical period can be credited to factors like the rising frequency of cancer, an increasing inclination towards less invasive ablation procedures, augmented health care expenditure, the endorsement of new ablation gadgets and technologies, better cancer screening initiatives, and an expanding elderly population.

What Growth Rate Is Anticipated for the Oncology Ablation Market in the Coming Years?

The oncology ablation market is projected to experience significant expansion in the coming years, with a forecasted growth to $2.35 billion by 2029 at a compound annual growth rate of 12.6%. This growth in the forecast period could be linked to the continuous improvements in ablation technology, the escalating adoption of these technologies in developing economies, the expansion of personalized and precision medicine, increased government support and funding for cancer research and innovative treatment methods, a heightened demand for outpatient procedures, and heightened awareness within the public and professional community. Key trends anticipated during the forecast period include the incorporation of artificial intelligence (AI), advancements in imaging technologies, the advent of robotic-assisted ablation, the launch of advanced ablation devices with heightened efficacy, safety, and ease-of-use, and the growing use of telemedicine for pre- and post-ablation care, allowing for remote patient monitoring and follow-ups.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

Who Are the Leading Companies in the Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

What Are the Key Drivers of the Oncology Ablation Market?

The escalation in cancer diagnoses is anticipated to fuel the expansion of the oncology ablation market in the future. The term ‘cancer diagnosis’ relates to the identification and affirmation of cancer presence through various medical assessments, imaging procedures, and pathological tissue sample analyses. The upsurge in cancer diagnoses can be attributed to multiple factors, including an aging population, enhancement in screening programs, increased awareness leading to early detection, and environmental influences. Oncology ablation, utilized for treating tumors identified via cancer diagnoses, provides less invasive solutions to eradicate tumors and augment patient results. In May 2024, as reported by the National Cancer Institute – the principal US-based federal government agency responsible for cancer research and training – approximately 2,001,140 fresh cancer cases are anticipated in the United States, with prostate, lung, and colorectal cancers constituting nearly 48% of all diagnoses in males. By 2040, the yearly count of new cancer cases is expected to skyrocket to 29.9 million, underscoring a substantial forthcoming escalation in cancer occurrence. Additionally, in June 2022, as reported by the American Cancer Society – a US-based non-profit organization dedicated to cancer awareness – nearly 1.9 million fresh cancer cases were identified in the US in 2022. Hence, the growing count of cancer diagnoses is set to stimulate the oncology ablation market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

What Are the Key Market Segments in the Oncology Ablation Industry?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Are the Latest Trends in the Oncology Ablation Market?

Key players in the oncology ablation market are pushing the boundaries through the development of ground-breaking products. These include sophisticated ablation systems bolstered by greater precision, incorporated imaging technologies for real-time guidance, and added safety measures. Advanced ablation systems offering enhanced precision are medical appliances that exploit cutting-edge technology to pinpoint and annihilate abnormal tissue, like tumors, while safeguarding nearby healthy tissue. For example, in March 2024, Medtronic Plc, a medical instrumentation production company headquartered in Ireland, obtained approval for the OsteoCool 2.0 bone tumor ablation system from the US Food and Drug Administration. This system, purpose-built to treat painful bone metastases and benign tumors such as osteoid osteoma, boasts considerable improvements, including the capacity to employ four internally cooled probes at the same time. This permits simultaneous ablation of two vertebral bodies or formation of larger ablation zones in non-spinal applications.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

What Are the Key Regional Markets in the Oncology Ablation Industry?

North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415

This Report Delivers Insight On:

1. How big is the oncology ablation market, and how is it changing globally?

2. Who are the major companies in the oncology ablation market, and how are they performing?

3. What are the key opportunities and risks in the oncology ablation market right now?

4. Which products or customer segments are growing the most in the oncology ablation market?

5. What factors are helping or slowing down the growth of the oncology ablation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theOncology Ablation Market from 2025 to 2034?

The increasing number of cancer diagnoses is fueling the oncology ablation market. Cancer detection is rising due to aging, awareness, and better screening. Oncology ablation offers a minimally invasive way to destroy tumors. The National Cancer Institute projected in May 2024 that 2,001,140 new cancer cases would be diagnosed in 2024 in the U.S., with cases expected to reach 29.9 million by 2040. Hence, cancer diagnosis trends are accelerating oncology ablation market growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

#How Will the CAGR of the Oncology Ablation Market Influence Its Overall Growth by 2034?

The oncology ablation market witnessed rapid growth, moving from $1.3 billion in 2024 to $1.46 billion in 2025 at a CAGR of 12.9%. This increase was supported by the rising prevalence of cancer, growing preference for minimally invasive techniques, higher healthcare spending, approvals of advanced ablation devices, improved cancer screening, and a growing elderly population.

The oncology ablation market is expected to grow rapidly, reaching $2.35 billion in 2029 at a CAGR of 12.6%. Growth factors include advancements in ablation technology, increasing adoption in emerging economies, the rise of personalized and precision medicine, government support for cancer research, growing demand for outpatient procedures, and increased awareness. Trends include AI integration, advancements in imaging technologies, robotic-assisted ablation, advanced ablation devices, and telemedicine for pre- and post-ablation care.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415

How Are Market Trends and Innovations Revolutionizing theOncology Ablation Industry in Recent Times?

Major companies in the oncology ablation market are developing advanced ablation systems with precision and integrated imaging. In March 2024, Medtronic Plc received FDA approval for OsteoCool 2.0, capable of using four probes simultaneously for enhanced tumor ablation.

Which Key Market Players Are Shaping the Future and Growth of theOncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

What Are the Core Segments of the Oncology Ablation Market, and How Do They Contribute to Growth?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

What Regions Are Dominating the Oncology Ablation Market Growth?

North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Oncology Ablation Market 2025, By The Business Research Company:

Interventional Oncology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Oncology Molecular Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Discover trends, market shifts, and competitive outlooks for the oncology ablation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Milestones in the Oncology Ablation Market’s Growth Trajectory From 2025 To 2034?#_x000D_

The size of the oncology ablation market has swiftly expanded in the past few years, with growth predicted to continue from $1.3 billion in 2024 to $1.46 billion in 2025, representing a compound annual growth rate (CAGR) of 12.9%. This historic growth pattern is due to several factors, including the rising incidence of cancer, a growing preference for minimally invasive ablation procedures, heightened healthcare expenditure, the approval of new ablation devices and methodologies, enhanced cancer screening initiatives, and a surge in the elderly population._x000D_

_x000D_

The market for oncology ablation is anticipated to experience substantial growth in the forthcoming years. It is projected to reach $2.35 billion by the year 2029, with an expected compound annual growth rate (CAGR) of 12.6%. The predicted expansion in the forecast period is due to continuous improvements in ablation technology, wider acceptance of these techniques in developing economies, an increase in targeted and personalized medical treatments, augmented government support and investment in cancer research and treatment developments as well as an increased demand for outpatient procedures and heightened public and professional consciousness. Key trends for the forecast period include the incorporation of artificial intelligence (AI), progress in imaging technologies, robot-assisted ablation procedures, the launch of more sophisticated ablation devices with better efficacy, safety, and ease-of-use, and the advent of telemedicine for care before and after ablation, allowing for remote monitoring and follow-ups._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp_x000D_

_x000D_

#What Are the Core Growth Drivers Propelling the Oncology Ablation Market Forward?#_x000D_

The growth of the oncology ablation market is predicted to soar with the rising number of cancer diagnoses. This surge in cancer detection stems from a variety of aspects including an aging demographic, enhanced screening initiatives, elevated cognizance leading to earlier discovery, and environmental influences. Oncology ablation serves as a treatment method for tumors found through cancer diagnoses, providing less invasive alternatives to eliminate tumors and enhance patient prognosis. For example, the National Cancer Institute, a US-based federal agency focusing on cancer research and training, anticipates around 2,001,140 new cancer cases in the United States by May 2024. Prostate, lung, and colorectal cancers are estimated to make up about 48% of all diagnoses among men. By 2040, the yearly number of fresh cancer cases is foreseen to reach 29.9 million, underlining a substantial future rise in cancer prevalence. In addition, the American Cancer Society, a US-based non-profit dedicated to cancer awareness, reported about 1.9 million new cancer cases in the USA in June 2022. Thus, the escalating number of cancer detections is anticipated to fuel the oncology ablation market._x000D_

_x000D_

#Which Key Market Segments Comprise the Oncology Ablation Market and Drive Its Revenue Growth?#_x000D_

The oncology ablation market covered in this report is segmented –_x000D_

_x000D_

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation_x000D_

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation_x000D_

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer_x000D_

_x000D_

Subsegments:_x000D_

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation_x000D_

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation_x000D_

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation_x000D_

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Oncology Ablation Market?#_x000D_

North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Current Market Growth and Trends in the Oncology Ablation Industry?#_x000D_

Leading corporations in the oncology ablation market are focusing on developing ground-breaking products such as advanced ablation devices with improved accuracy, integrated imaging tech for immediate guidance, and augmented safety characteristics. These advanced ablation mechanisms employ the latest technology to accurately target and eradicate abnormal cells like tumors, without significantly damaging the surrounding healthy tissues. For example, the prominent Ireland-based medical equipment manufacturer, Medtronic Plc, acquired the approval from the US Food and Drug Administration in March 2024, for the release of their upgraded OsteoCool 2.0 bone tumor ablation system. This device, specifically designed to treat painful bone metastases and benign osteoid osteoma tumors, encompasses substantial enhancements like the capability to employ four internally cooled probes at once, facilitating the ablation of dual vertebral bodies simultaneously or enabling the creation of larger ablation areas in non-spinal uses._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report_x000D_

_x000D_

#How Is the Oncology Ablation Market Conceptually Defined?#_x000D_

Oncology ablation refers to a minimally invasive procedure used to destroy cancerous tumors. It involves the application of extreme conditions directly to the tumor tissue. This technique aims to reduce or eliminate tumors while sparing surrounding healthy tissue._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the oncology ablation market size evolved in recent years?

In recent years, the oncology ablation market has experienced significant expansion. Its worth is projected to increase from $1.3 billion in 2024 to $1.46 billion in 2025, showing a compound annual growth rate (CAGR) of 12.9%. Several factors have contributed to this growth during the historic period, including the rising incidence of cancer, an upsurge in the preference for less invasive ablation procedures, augmented healthcare expenses, the approval of new ablation tools and technologies, enhanced cancer screening initiatives, and an increase in the elderly population.

What are the predictions for the oncology ablation market size in the coming years?

The market size for oncology ablation is predicted to experience significant growth in the upcoming years, ultimately reaching a value of $2.35 billion in 2029 with a compound annual growth rate (CAGR) of 12.6%. This radical growth can be linked to the multiple advancements in the sphere of ablation technology, coupled with its increasing acceptance in progressing economies. Further factors contributing to the growth are inclinations towards personalised and precision medicine, heightened government aid and funding towards cancer research and treatments, and a growing demand for outpatient services. Better public and professional understanding also plays a role in the growth. The forecast period highlights several key trends including the use of artificial intelligence (AI) in the field, progression in imaging technologies, the employment of robotic-aided ablation, the emergence of advanced ablation tools designed for higher efficiency, safety, and user comfort, and the adoption of telemedicine for initial and follow-up ablation care, making remote monitoring feasible.

Get your oncology ablation market report here!

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

What key factors are fueling the growth of the oncology ablation market?

The growth of the oncology ablation market is expected to be driven by the rising number of cancer diagnoses. Cancer diagnosis involves the determination and confirmation of cancer presence via medical examinations, imaging, and pathological tissue sample analyses. The escalating number of cancer diagnoses can be attributed to a variety of reasons, including an aging population, more efficient screening programs, increased awareness leading to earlier detection, and environmental factors. Oncology ablation, a method used to treat tumors identified through cancer diagnoses, provides less invasive alternatives to eliminate tumors and enhance patient results. For example, the National Cancer Institute, the main agency of the U.S. federal government for cancer research and training, projected in May 2024 that there will be approximately 2,001,140 new cancer instances in the U.S. in 2024, with prostate, lung, and colorectal cancers accounting for about 48% of all diagnoses in males. By 2040, it’s predicted that the yearly number of novel cancer cases will rise to 29.9 million, indicating a substantial future rise in cancer rates. The American Cancer Society, a nonprofit organization in the U.S. that focuses on cancer awareness, reported in June 2022 that there were approximately 1.9 million new cancer cases diagnosed in the U.S. in 2022. As such, the oncology ablation market is anticipated to be propelled by the increased number of cancer diagnoses.

How is the global oncology ablation market divided into key segments?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

Who are the key firms paving the way for growth in the oncology ablation market?

Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

How are evolving market trends shaping oncology ablation Strategies?

Leading firms in the oncology ablation industry are pushing boundaries with innovative products such as advanced ablation systems featuring superior precision, integrated real-time imaging technology, and enhanced safety attributes. Precise advanced ablation systems refer to healthcare devices that utilize cutting-edge technology to specifically target and obliterate irregular tissue like tumors, whilst mitigating damage to neighboring healthy tissue. For example, Medtronic Plc, an Irish maker of medical equipment, obtained U.S. Food and Drug Administration approval in March 2024 for their OsteoCool 2.0 bone tumor ablation system. This system, designed to address painful bone metastases and benign tumors like osteoid osteoma, brings major improvements. These include the capacity to utilize four internally cooled probes concurrently, enabling the ablation of two vertebral bodies together, or developing larger ablation zones for non-spinal applications.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415

What regions are contributing significantly to the growth of the oncology ablation market?

North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Interventional Oncology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Oncology Molecular Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How Rapidly is the Oncology Ablation Market Forecasted to Grow Between 2024 and 2033?

The oncology ablation market size has expanded rapidly in recent years. It is anticipated to grow from $1.15 billion in 2023 to $1.30 billion in 2024, reflecting a CAGR of 12.6%. The historical growth can be attributed to the rising prevalence of cancer, a preference for minimally invasive ablation techniques, increased healthcare spending, approvals for new ablation devices and technologies, improved cancer screening programs, and a growing geriatric population.

The oncology ablation market size is expected to experience rapid growth in the next few years, projected to reach $2.09 billion by 2028 at a compound annual growth rate (CAGR) of 12.7%. This growth can be attributed to ongoing advancements in ablation technology, increasing adoption of ablation technologies in emerging markets, the growth of personalized and precision medicine, rising governmental support and funding for cancer research and treatment innovations, a growing demand for outpatient procedures, and enhanced awareness among the public and professionals. Key trends during the forecast period include the integration of artificial intelligence (AI), advancements in imaging technologies, robotic-assisted ablation, the introduction of advanced ablation devices with improved efficacy, safety, and user-friendliness, and the utilization of telemedicine for pre- and post-ablation care to facilitate remote monitoring and follow-up.

What Factors Are Behind the Rapid Growth of the Oncology Ablation Market?

The rising number of cancer diagnoses is set to accelerate the growth of the oncology ablation market. Cancer diagnosis involves identifying and confirming cancer presence through medical testing, imaging, and pathological analysis of tissue samples. The rising diagnosis rates can be attributed to factors such as an aging population, enhanced screening programs, increased awareness for early detection, and environmental influences. Oncology ablation is utilized to treat tumors found during cancer diagnoses, offering minimally invasive procedures to destroy tumors and improve patient outcomes.

Claim Your Free Sample of the Global Oncology Ablation Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Are the Principal Segments of the Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation
2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

What Emerging Patterns Are Redefining the Oncology Ablation Market?

Major companies in the oncology ablation market are focused on developing innovative products, such as advanced ablation systems that offer improved precision, integrated imaging technologies for real-time guidance, and

Order Now for Fast Delivery of Your Oncology Ablation Market Report!

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Geographical Regions Are Shaping the Oncology Ablation Market Growth?

North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Oncology Ablation Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oncology ablation market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Oncology Ablation Market Include

1. Oncology Ablation Market Executive Summary
2. Oncology Ablation Market Segments
3. Oncology Ablation Market Size And Template Market Growth Rate
4.  Key Oncology Ablation Market Trends
5. Major Oncology Ablation Market Drivers
……
25. Key Mergers And Acquisitions In The Oncology Ablation Market
26. Top Oncology Ablation Companies
27. Oncology Ablation Market Opportunities And Strategies
28. Oncology Ablation Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:

Immuno-Oncology Drugs Market Overview, Industry Growth And Forecast 2024-2033

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report

Oncology Molecular Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

Oncology Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Oncology Ablation Global Market Report 2024, the oncology ablation market is expected to show promising growth in the forecast period.

The oncology ablation market has seen significant expansion in recent years and is poised for continued growth. From a market size of $1.15 billion in 2023, it is projected to reach $1.30 billion in 2024, representing a compound annual growth rate (CAGR) of 12.6%. This surge can be attributed to several key factors driving the industry forward.

Drivers of Market Growth

• Increasing Cancer Prevalence: The rising global incidence of cancer has driven demand for more advanced treatment options.
• Minimally Invasive Techniques: Growing preference for less invasive procedures has made ablation techniques more popular among patients and physicians.
• Healthcare Spending and Approvals: Increased healthcare budgets and the approval of new ablation devices have played a crucial role in market expansion.
• Improved Screening and Geriatric Population: Advancements in cancer screening programs and an aging global population have further fueled the growth of oncology ablation.

View More On The Oncology Ablation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Future Outlook for Oncology Ablation

The market is expected to continue growing, reaching $2.09 billion by 2028, with a CAGR of 12.7%. Several factors are expected to drive this growth in the forecast period.

• Advancements in Technology: Ongoing innovations in ablation devices will enhance treatment precision, efficacy, and safety.
• Emerging Economies: Increased adoption of ablation technologies in developing regions will contribute to market growth.
• Personalized Medicine: The rise of precision medicine is enabling more targeted cancer treatments, benefiting ablation technologies.
• Governmental Support: Increased funding for cancer research and treatment innovations is expected to accelerate the adoption of ablation techniques.
• Outpatient Procedures: Growing demand for outpatient procedures will drive the popularity of minimally invasive ablation treatments.

Key Market Trends

Several important trends are shaping the future of the oncology ablation market:

• AI Integration: Artificial intelligence is becoming integral to enhancing treatment accuracy and patient outcomes.
• Robotic-Assisted Ablation: Robotics is improving the precision and control of ablation procedures.
• Telemedicine: Telemedicine is transforming pre- and post-ablation care, enabling remote monitoring and follow-up.
• Advanced Imaging Technologies: Improved imaging systems are providing real-time guidance during ablation, enhancing accuracy and safety.

The Impact of Rising Cancer Diagnoses

One of the most significant drivers of the oncology ablation market is the increasing number of cancer diagnoses. For instance, the U.S. is expected to see 2,001,140 new cancer cases in 2024, with prostate, lung, and colorectal cancers accounting for nearly half of all diagnoses in men. This rising trend is driven by an aging population, enhanced cancer screening programs, and greater awareness, leading to earlier detection. As more cases are diagnosed, the demand for oncology ablation technologies will continue to grow, offering patients minimally invasive options for tumor destruction.

Key Players in the Market

Several major companies are actively driving innovation in the oncology ablation market, including:

• Medtronic Plc: Received FDA approval for its OsteoCool 2.0 bone tumor ablation system in 2024, showcasing significant advancements in precision and usability.
• Boston Scientific Corporationand GE Healthcare Technologies Inc.: Among other key players developing advanced ablation systems with integrated imaging and safety features.

Regional Market Insights

North America led the global oncology ablation market in 2023, but the Asia-Pacific region is expected to see the fastest growth through 2028. The regions covered include:

• North America
• Western and Eastern Europe
• Asia-Pacific
• South America
• Middle East
• Africa

Conclusion

The oncology ablation market is experiencing rapid growth, driven by technological advancements, increasing cancer diagnoses, and rising demand for minimally invasive treatments. With innovations in AI, robotic systems, and telemedicine, the future of oncology ablation looks promising, offering improved patient outcomes and expanding treatment options across the globe.

Request A Sample Of The Global Oncology Ablation Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=18415&type=smp